| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/09/2013 | CA2505655C Stable, water-soluble quantum dot, method of preparation and conjugates thereof |
| 07/09/2013 | CA2500884C Buffy coat separator float system and method |
| 07/09/2013 | CA2463641C Antisense antiviral agent and method for treating ssrna viral infection |
| 07/09/2013 | CA2457987C System, method, and apparatus for detecting breach of exposure protection equipment |
| 07/09/2013 | CA2447085C Process to extract gluten from heat-treated or non heat-treated food products, compatible with elisa, composition and kits that contain this composition |
| 07/09/2013 | CA2437583C Dna markers for meat tenderness |
| 07/09/2013 | CA2435743C Locating a source of emanations |
| 07/09/2013 | CA2369413C Transmembrane protein expressed in prostate and other cancers |
| 07/09/2013 | CA2354804C Method and solid phase calibration sample for calibration of analytical instruments |
| 07/09/2013 | CA2348152C Vessel for withdrawing blood |
| 07/08/2013 | DE202010017997U1 Vorrichtung zum Erkennen und Korrigieren von Fehlstellen in Holz Apparatus for detecting and correcting defects in wood |
| 07/06/2013 | CA2800722A1 Systems and methods for multivariate analysis of adverse event data |
| 07/04/2013 | WO2013102187A1 Methods and compositions for diagnosing and treating cancer |
| 07/04/2013 | WO2013102149A1 Truncated human vitamin d binding protein and mutation and fusion thereof and related materials and methods of use |
| 07/04/2013 | WO2013102093A1 Multiple- analyte assay device and system |
| 07/04/2013 | WO2013102088A2 Highly Sensitive Cell-Based Assay to Detect the Presence of Active Botulinum Neurotoxin Serotype-A |
| 07/04/2013 | WO2013102076A1 Method and apparatus for automated platelet identification within a whole blood sample from microscopy images |
| 07/04/2013 | WO2013101989A1 Automated analysis of circulating tumor cells |
| 07/04/2013 | WO2013101892A1 Methods for detecting hyperglycosylated human chorionic gonadotropin (hcg-h) |
| 07/04/2013 | WO2013101758A1 Biomarkers for kawasaki disease |
| 07/04/2013 | WO2013101617A1 Method for assessing a liver of a patient having a chronic hepatitis b virus infection |
| 07/04/2013 | WO2013101603A1 Cellular analysis of body fluids |
| 07/04/2013 | WO2013101436A1 Methods of identifying and using mdm2 inhibitors |
| 07/04/2013 | WO2013101381A1 Colorimetric determination of the total oil content of a plant tissue sample using alkaline saponification |
| 07/04/2013 | WO2013101276A2 Diagnosis and detection of disease conditions modulated by activation of the sphingolipid pathway |
| 07/04/2013 | WO2013100949A1 Nanogap transducers with selective surface immobilization sites |
| 07/04/2013 | WO2013100858A1 A method or device for identifying inhibitor of epithelial mesenchymal transition |
| 07/04/2013 | WO2013100855A1 A novel phosphotyrosine-binding structure |
| 07/04/2013 | WO2013100847A1 Method for detection of binding |
| 07/04/2013 | WO2013100522A1 Method of automatically setting unit of measurement of bio-data measuring device |
| 07/04/2013 | WO2013100251A1 Screening methods for anticancer agents by examining the extent of methylation of pontin |
| 07/04/2013 | WO2013098821A1 Methods and systems for detecting a pathogen in a biological sample |
| 07/04/2013 | WO2013098786A1 Method for the in vitro diagnosis of parkinson's disease |
| 07/04/2013 | WO2013098264A1 Inhibitor of trpm-4 ion channel for treating or preventing neurodegeneration |
| 07/04/2013 | WO2013098123A1 Histone deacetylase 10-inhibitor co-treatment in cancer |
| 07/04/2013 | WO2013096994A1 Media absorbency determination |
| 07/04/2013 | WO2013074399A3 Process for predicting degree of mottling in coating compositions by wet color measurement |
| 07/04/2013 | WO2013071450A9 A method for assaying the activity of spermidine/spermine n1-acetyltrasferase |
| 07/04/2013 | WO2013071413A8 Methods for the synthesis of 13c labeled iodotridecane and use as a reference standard |
| 07/04/2013 | WO2013071412A8 Methods for the synthesis of 13c labeled plasmalogen |
| 07/04/2013 | WO2013071411A8 Methods for the synthesis of 13c labeled dha and use as a reference standard |
| 07/04/2013 | WO2013071127A8 Monoclonal antibodies against serotransferrin antigens, and uses therefor |
| 07/04/2013 | WO2013070943A3 Small molecule screen for inhibitors of nfat:ap-1:dna interactions |
| 07/04/2013 | WO2013067397A9 Zap-70 detection in chronic lymphocytic leukemia |
| 07/04/2013 | WO2013058578A3 System for screening skin-whitening material |
| 07/04/2013 | WO2013058572A3 Hydrogel patterning and transferring method of cells, and cell-based biosensor using same |
| 07/04/2013 | WO2013056250A3 Cxcr4 inhibiting carriers for nucleic acid delivery |
| 07/04/2013 | WO2013056211A3 Telomerase reverse transcriptase deficience as diagnostic marker of myelodysplastic syndrome |
| 07/04/2013 | WO2013055142A3 Method for manufacturing multi-functional bio-material conjugate using two kinds of particle, and multi-functional bio-material conjugate manufactured by means of same |
| 07/04/2013 | WO2013054230A3 Method for detection of coagulation activity and biomarkers. |
| 07/04/2013 | WO2013051890A3 Method for manufacturing multiple-diagnosis membrane sensor by using screen printing |
| 07/04/2013 | WO2013051889A3 Membrane sensor enabled with sequential change of reaction condition with single sample injection |
| 07/04/2013 | WO2013051710A9 Diagnostic marker for gastrointestinal cancer, and testing method for gastrointestinal cancer |
| 07/04/2013 | WO2013049362A3 Method of treating multiple sclerosis by intrathecal depletion of b cells and biomarkers to select patients with progressive multiple sclerosis |
| 07/04/2013 | WO2013042877A3 Biosensor and measurement apparatus for same |
| 07/04/2013 | WO2013025261A9 Fluorogenic peptide probes and assays |
| 07/04/2013 | WO2013024467A3 Mitochondrial ribosomal proteins as aging regulators |
| 07/04/2013 | WO2012167139A3 Engineered respiratory syncytial viruses with control of cell-to-cell virus transmission for enhanced safety of live virus vaccines |
| 07/04/2013 | WO2012125733A3 Antibody screening methods |
| 07/04/2013 | WO2012123560A3 A method for controlling a cooking process of food stuff, and a food probe for use in this method |
| 07/04/2013 | WO2012078327A3 Fluid system health monitor |
| 07/04/2013 | WO2012061785A3 Ice inhibiting compounds and uses thereof |
| 07/04/2013 | US20130174293 Colorimetric determination of the total oil content of a plant tissue sample using alkaline saponification |
| 07/04/2013 | US20130173176 Biological sample measurement system |
| 07/04/2013 | US20130172431 Diagnostic test |
| 07/04/2013 | US20130172263 Vh4 codon signature for multiple sclerosis |
| 07/04/2013 | US20130172261 Use of 2 anti-sparc antibodies to predict response to chemotherapy |
| 07/04/2013 | US20130172253 Method of diagnosing and treating oxidative stress-impaired wound healing |
| 07/04/2013 | US20130172251 Modified ghrelin peptides |
| 07/04/2013 | US20130172216 Arrays and Methods of Use |
| 07/04/2013 | US20130172210 Method of drug design |
| 07/04/2013 | US20130172207 Fluorescence enhancing plasmonic nanoscopic gold films and assays based thereon |
| 07/04/2013 | US20130172205 Markers of acute kidney failure |
| 07/04/2013 | US20130172204 Diagnostic Methods for Glaucoma |
| 07/04/2013 | US20130172203 Hybrid model for the classification of carcinoma subtypes |
| 07/04/2013 | US20130172202 Sensor and method for detection of a target substance |
| 07/04/2013 | US20130172198 Cells for chromatin immunoprecipitation and methods for making |
| 07/04/2013 | US20130171739 Microchip solution sending system |
| 07/04/2013 | US20130171727 T1r taste receptors and genes encoding same |
| 07/04/2013 | US20130171683 Flow cytometer apparatus and method |
| 07/04/2013 | US20130171676 Method for measuring glycated hemoglobin |
| 07/04/2013 | US20130171674 Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
| 07/04/2013 | US20130171673 Pipette tip, pipette system and method for performing analysis with the pipette tip and system |
| 07/04/2013 | US20130171672 Methods for Detecting Oncofetal Fibronectin |
| 07/04/2013 | US20130171670 Diagnosis and monitoring of inflammation, ischemia and appendicitis |
| 07/04/2013 | US20130171669 Porous membranes having a hydrophilic coating and methods for their preparation and use |
| 07/04/2013 | US20130171666 Purinergic (P2X) Receptors in Extra-Cellular Body Fluid |
| 07/04/2013 | US20130171665 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory |
| 07/04/2013 | US20130171662 Assay |
| 07/04/2013 | US20130171660 Blood marker for renal cancer |
| 07/04/2013 | US20130171659 Methods of prognosis and diagnosis of rheumatoid arthritis |
| 07/04/2013 | US20130171658 Isolation and deglycosylation of glycoproteins |
| 07/04/2013 | US20130171650 Identification of fetal dna and fetal cell markers in maternal plasma or serum |
| 07/04/2013 | US20130171634 Biomarkers for cancers responsive to modulators of hec1 activity |
| 07/04/2013 | US20130171628 Method and device for isolating cells from heterogeneous solution using microfluidic trapping vortices |
| 07/04/2013 | US20130171624 Magnetic Binding Assays Utilizing Time-Resolved Up-Converting Luminescence Detection |
| 07/04/2013 | US20130171623 Binding Assays Utilizing Time-Resolved Up-Converting Luminescence Detection |
| 07/04/2013 | US20130171619 Porous membranes having a hydrophilic coating and methods for their preparation and use |
| 07/04/2013 | US20130171618 Porous membranes having a polymeric coating and methods for their preparation and use |
| 07/04/2013 | US20130171331 Stimuli Responsive Nanofibers |